The efficacy of laser hair removal therapy in patients with mild to moderate HS, a randomized controlled trial.

Not yet recruiting

• Conditions: Acne inversa; Verneuil's disease; 10040798

• Registration Number: NL-OMON53989
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 58

Inclusion Criteria

- IHS4 mild to moderate, without tunnels in the axillae and/or inguinal area.
- HS activity in at least one axilla or at least one side of the inguinal area.
- Age 16 years and over.

Exclusion Criteria

- If the patient is not able to give informed consent.
- If the patient is allergic to clindamycin lotion.
- If the patient uses systemic therapy for HS such as antibiotics or
biologicals.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoint of this study is the difference in IHS4 between the<br /><br>intervention group and the control group over month 7 to 12, using a repeated<br /><br>measure analysis. </p><br>